Missouri HB3059 mandates insurance coverage for prescription drugs treating advanced, metastatic cancer without prior drug failure requirements.
Missouri HB3059 introduces provisions requiring insurance coverage for prescription drugs treating advanced, metastatic cancer and associated conditions. It prohibits insurers from demanding proof of failure with another drug before covering a new one. This applies to drugs supported by peer-reviewed literature and approved by the FDA. The bill defines "advanced, metastatic cancer" and "associated condition" for clarity.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.